Illumina forced to pay almost $334M as it loses DNA sequencing patent case

Illumina forced to pay almost $334M as it loses DNA sequencing patent case

Source: 
Endpoints
snippet: 

A federal jury in Delaware on Friday ordered Illumina to pay Complete Genomics Inc., a subsidiary of the BGI Group, the world’s largest maker of commercial genetic sequencers, almost $334 million, finding Illumina infringed on two DNA sequencing patents.